These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MIR1246 in body fluids as a biomarker for pancreatic cancer. Ishige F; Hoshino I; Iwatate Y; Chiba S; Arimitsu H; Yanagibashi H; Nagase H; Takayama W Sci Rep; 2020 May; 10(1):8723. PubMed ID: 32457495 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Salivary Exosome as Potential Biomarkers of Aging. Machida T; Tomofuji T; Ekuni D; Maruyama T; Yoneda T; Kawabata Y; Mizuno H; Miyai H; Kunitomo M; Morita M Int J Mol Sci; 2015 Sep; 16(9):21294-309. PubMed ID: 26370963 [TBL] [Abstract][Full Text] [Related]
4. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715 [TBL] [Abstract][Full Text] [Related]
5. Salivary MicroRNA in Pancreatic Cancer Patients. Humeau M; Vignolle-Vidoni A; Sicard F; Martins F; Bournet B; Buscail L; Torrisani J; Cordelier P PLoS One; 2015; 10(6):e0130996. PubMed ID: 26121640 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130 [TBL] [Abstract][Full Text] [Related]
7. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191 [TBL] [Abstract][Full Text] [Related]
8. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588 [TBL] [Abstract][Full Text] [Related]
9. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097 [TBL] [Abstract][Full Text] [Related]
10. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Kitagawa T; Taniuchi K; Tsuboi M; Sakaguchi M; Kohsaki T; Okabayashi T; Saibara T Mol Oncol; 2019 Feb; 13(2):212-227. PubMed ID: 30358104 [TBL] [Abstract][Full Text] [Related]
11. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087 [TBL] [Abstract][Full Text] [Related]
12. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis. Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599 [TBL] [Abstract][Full Text] [Related]
13. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples. Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129 [TBL] [Abstract][Full Text] [Related]
14. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus. Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015 [TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer. Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318 [TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-1246 in body fluids is a potential biomarker for gastrointestinal cancer. Wei C; Li Y; Huang K; Li G; He M Biomark Med; 2018 Oct; 12(10):1185-1196. PubMed ID: 30235938 [TBL] [Abstract][Full Text] [Related]
18. Role of pancreatic cancer-derived exosomes in salivary biomarker development. Lau C; Kim Y; Chia D; Spielmann N; Eibl G; Elashoff D; Wei F; Lin YL; Moro A; Grogan T; Chiang S; Feinstein E; Schafer C; Farrell J; Wong DT J Biol Chem; 2013 Sep; 288(37):26888-97. PubMed ID: 23880764 [TBL] [Abstract][Full Text] [Related]
19. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer. Joyce DP; Kerin MJ; Dwyer RM Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104 [TBL] [Abstract][Full Text] [Related]
20. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Bloemena E; Wong DT Clin Cancer Res; 2013 Jun; 19(11):3032-8. PubMed ID: 23575476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]